Serveur d'exploration sur les pandémies grippales - Curation (Accueil)

Index « DoubleIdat.i » - tête de navigation
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Index : DoubleIdat.i

Pour accéder à une entrée :

Les termes de plus forte occurence

18756-7938:2005:Hoare M:bioprocess:engineering:issues
11935-7893:2013:Davies A:testing:the:efficacy
11931-3128:2016:Spyrou M:historical:y:pestis
11875-9572:2010:Ho T:historical:review:of
11874-5482:2014:Tuncer N:effect:of:air
11865-1674:2016:Dorjee S:one:health:simulation
11775-8785:2008:Gehanno J:le:medecin:du
11750-2640:2013:Smith R:macroeconomic:impact:of
11660-9379:2007:Zanetti G:pandemie:de:grippe
11635-0421:2008:Ezratty V:virus:influenza:pandemique
11635-0421:2007:Legeas M:une:pandemie:grippale
11600-6135:2006:Kumar D:pandemic:influenza:and
11567-1348:2012:Vittecoq M:study:of:influenza
11549-1277:2007:Colizza V:modeling:the:worldwide
11545-9624:2013:Gardner P:viable:viral:efficiency
11473-3099:2012:Simpson C:effectiveness:of:h
11473-3099:2009:Cauchemez S:closure:of:schools
11473-3099:2008:Jennings L:stockpiling:prepandemic:influenza
11473-3099:2008:Fedson D:confronting:an:influenza
11473-3099:2007:Brankston G:transmission:of:influenza
11473-3099:2006:Brundage J:interactions:between:influenza
11473-3099:2005:Witt C:a:veterinarian:s
11470-2118:2008:Barr H:ethical:planning:for
11470-0328:2012:K Llen B:vaccination:against:h
11460-2725:2010:Mu Y:clinical:features:treatments
11460-2725:2010:Koegelenberg C:high:mortality:from
11434-6621:2010:Maritz J:pandemic:influenza:a
11434-193X:2008:Shibasaki M:synthetic:strategies:for
11424-6074:2002:Li S:seed:viruses:containing
11386-6532:2011:Poon L:viral:genetic:sequence
11386-6532:2011:Foucault M:role:for:proteases
11386-6532:2009:Chan K:analytical:sensitivity:of
11386-6532:2008:Mackay W:molecular:detection:and
11368-5031:2011:Theocharis G:comparison:of:characteristics
11359-6535:2009:Prabhu N:prophylactic:and:therapeutic
11359-6535:2007:Crusat M:neuraminidase:inhibitors:and
11359-107X:2014:Taha S:intolerance:of:uncertainty
11359-107X:2012:Teasdale E:the:importance:of
11355-0284:2008:Mccall S:the:relationship:between
11326-0200:2006:Clothier H:geographic:representativeness:for
11323-1316:2012:Matsuishi K:psychological:impact:of
11286-4579:2001:Reid A:the:spanish:influenza
11201-9712:2007:Cheng K:what:happened:in
11198-743X:2010:D Ortenzio E:a:review:of
11188-4169:2018:Henry B:canadian:pandemic:influenza
11188-4169:2018:Henry B:canada:s:pandemic
11170-229X:2008:Kasten M:influenza:vaccination:and
11080-6040:2009:Macintyre C:face:mask:use
11080-6040:2008:Oshitani H:major:issues:and
11080-6040:2004:Drancourt M:genotyping:orientalis:like
11058-4838:2013:Richards J:neonatal:outcomes:after
11058-4838:2011:Hernandez J:clinical:experience:in
11058-4838:2011:Charu V:mortality:burden:of
11058-4838:2010:Morens D:pandemic:influenza:s
11058-4838:2010:Mccullers J:recipients:of:vaccine
11058-4838:2009:Beigi R:economic:value:of
11058-4838:2008:Trilla A:the:spanish:flu
11058-4838:2008:Monto A:seasonal:and:pandemic
11058-4838:2008:Bartlett J:the:current:status
11058-4838:2007:Hota S:antivirals:and:the
11058-4838:2007:Apisarnthanarak A:issues:relevant:to
11058-4838:2006:Ortiz J:a:national:survey
11058-4838:2006:Fedson D:pandemic:influenza:a
11058-4838:2005:Kaye D:avian:influenza:viruses
11058-4838:2003:Fedson D:pandemic:influenza:and
11058-4838:2002:Strikas R:influenza:pandemic:preparedness
11058-4838:2001:Luk J:observations:on:mortality
11058-4838:2000:Schoch Spana M:implications:of:pandemic
11058-4838:1999:Webster R:potential:advantages:of
11044-3983:2014:Huang K:the:us:a
11044-3983:2013:Wong J:case:fatality:risk
11044-3983:2007:Glass K:how:much:would
11025-496X:2005:Paget J:considerable:progress:in
11025-496X:2005:Ciotti M:results:of:survey
11025-496X:2002:Karcher F:plan:de:preparation
11025-496X:2002:Fock R:la:pandemie:de
11025-496X:2001:Paget W:les:plans:de
11004-3756:2013:Araz O:integrating:complex:system
10959-8138:2006:Moriarty K:the:influenza:pandemic
10959-8138:2004:Balicer R:tackling:the:next
10959-8138:2003:Zambon M:sudden:acute:respiratory
10959-8138:2003:Sheldon T:the:virus:hunter
10959-8138:1997:White R:when:the:next
10956-5663:2010:Chang Y:detection:of:swine
10956-3202:2007:Oxford J:the:threat:of
10951-631X:2003:Tognotti E:scientific:triumphalism:and
10951-631X:1994:Killingray D:the:influenza:pandemic
10950-2688:2013:Richard V:what:can:the
10950-2688:2013:Foster E:acute:myocardial:infarctions
10950-2688:2010:Shi P:modelling:seasonality:and
10950-2688:2010:Mclean E:pandemic:h:n
10950-2688:2010:Cowling B:face:masks:to
10950-2688:2009:Yuan J:reported:changes:in
10950-2688:2009:Richard S:a:comparative:study
10950-2688:2008:Rizzo C:scenarios:of:diffusion
10950-2688:2007:Duerr H:the:impact:of
10943-1853:2011:Naing C:knowledge:about:the
10939-6411:2012:Kim Y:increased:immunogenicity:of
10934-9723:2012:Saxena R:pandemism:of:swine
10934-9723:2010:Falagas M:epidemiological:aspects:of
10934-9723:2007:Beaumont M:a:survey:of
10931-0509:2009:Marcelli D:influenza:a:h
10929-693X:2008:Guery B:organisation:de:la
10928-8244:1997:Webster R:influenza:interspecies:transmission
10928-4249:2010:Busquets N:experimental:infection:with
10924-8579:2010:Falagas M:treatment:options:for
10923-2532:2010:Agut H:la:grippe:est
10920-9964:1999:Selten J:prenatal:exposure:to
10920-9964:1998:Selten J:prenatal:exposure:to
10903-4641:2010:Piwpankaew Y:distribution:of:viral
10899-823X:2005:Cinti S:preparing:for:pandemic
10893-8512:2012:Cheng V:two:years:after
10891-3668:2012:Fawkner Corbett D:the:impact:of
10891-3668:2012:Ede L:effect:of:the
10891-3668:2010:Ampofo K:association:of:pandemic
10891-3668:2008:Vesikari T:emerging:data:on
10891-3668:2008:Vajo Z:safety:and:immunogenicity
10891-3668:2008:Mccullers J:preparing:for:the
10891-3668:2008:Huber V:vaccines:against:pandemic
10891-3668:2005:Reichert T:preparing:for:the
10891-3668:2005:Perez D:avian:influenza:an
10891-3668:2004:Heymann A:influence:of:school
10891-3668:2004:Hayden F:pandemic:influenza:is
10891-3668:2004:Fedson D:vaccination:for:pandemic
10885-3924:2010:Downar J:palliating:a:pandemic
10803-5253:2012:Smit P:characterization:of:h
10767-0974:2009:Loulergue P:vaccins:pandemiques:et
10742-3071:2011:Zuccotti G:long:lasting:immunogenicity
10740-8218:1983:Ensley P:indiana:and:the
10737-1209:2010:Yonge O:willingness:of:university
10737-1209:2007:Macario E:preparing:public:health
10724-8741:2008:Amorij J:development:of:stable
10399-077X:2000:Mouton Y:recommandations:du:groupe
10393-2990:2012:Redlberger Fritz M:attributable:deaths:due
10393-2990:2011:Keil U:the:invention:of
10393-2990:2011:Gilles I:trust:in:medical
10393-2990:2011:Ferrante G:surveillance:of:perceptions
10393-2990:2011:Donker T:nowcasting:pandemic:influenza
10393-2990:2009:Raude J:lay:perceptions:of
10393-2990:2006:Van Der Heide D:no:effect:of
10393-2990:2003:Grais R:assessing:the:impact
10390-6078:2011:Ljungman P:outcome:of:pandemic
10378-1135:2012:Njabo K:pandemic:a:h
10378-1135:2011:Moreno A:novel:h:n
10378-1135:2010:Kalthoff D:highly:pathogenic:avian
10378-1135:2000:Shortridge K:interspecies:transmission:of
10378-1135:2000:Claas E:pandemic:influenza:is
10377-8231:2009:Snacken R:influenza:a:h
10342-4642:2011:Patroniti N:the:italian:ecmo
10342-4642:2011:Cuquemelle E:can:procalcitonin:help
10342-4642:2011:Bertolini G:is:influenza:a
10342-4642:2010:Sprung C:recommendations:for:intensive
10342-4642:2010:Ingram P:procalcitonin:and:c
10342-4642:2010:Eastman N:triaging:for:adult
10340-6199:2011:Lera E:clinical:and:epidemiological
10310-057X:2011:Boots R:experience:with:high
10309-2402:2006:Rassool G:current:issues:and
10309-0167:2012:Bal A:pathology:and:virology
10305-7453:2012:Delgado Rodriguez M:prognosis:of:hospitalized
10305-7453:2010:Reddy D:responding:to:pandemic
10305-7453:2006:Democratis J:use:of:neuraminidase
10305-7453:2005:Ward P:oseltamivir:tamiflu:and
10305-7453:2004:Oxford J:a:new:millennium
10304-8608:2011:Wanitchang A:atypical:characteristics:of
10304-8608:2010:Tolnay A:extrapulmonary:tissue:responses
10304-8608:2008:Lupfer C:inhibition:of:influenza
10304-8608:2000:Olsen C:virologic:and:serologic
10304-8608:2000:Okazaki K:precursor:genes:of
10304-8608:1996:Anchlan D:previous:h:n
10300-9564:2009:Foley P:encephalitis:lethargica:and
10300-8126:2011:Poeppl W:clinical:aspects:of
10300-8126:2011:Linhart Y:excess:mortality:from
10300-8126:2009:Michaelis M:an:influenza:a
10300-8126:2008:Lau J:perceptions:related:to
10300-5771:2007:Vynnycky E:estimates:of:the
10300-2977:2005:Groeneveld K:use:of:antiviral
10294-0337:2013:Aranzazu A:le:reseau:mondial
10277-9536:2012:Bensimon C:the:duty:to
10277-9536:2009:Noymer A:testing:the:influenza
10277-9536:2006:Mamelund S:a:socially:neutral
10277-9536:1999:Pyle G:from:african:health
10277-9536:1991:Ohadike D:diffusion:and:physiological
10277-9536:1983:Patterson K:the:diffusion:of
10277-0008:2006:Ford S:pandemics:avian:influenza
10272-4332:2013:Santos J:risk:based:input
10266-8254:2011:Kitajima M:dose:response:time
10264-410X:2014:Davila Payan C:system:factors:to
10264-410X:2013:Pulcini C:factors:associated:with
10264-410X:2011:Saglanmak N:gradual:changes:in
10264-410X:2011:Noymer A:the:influenza:pandemic
10264-410X:2011:Khurana S:recombinant:ha:produced
10264-410X:2011:Hatta Y:an:m:cytoplasmic
10264-410X:2011:Ellebedy A:impact:of:prior
10264-410X:2011:Cotte L:factors:associated:with
10264-410X:2011:Chowell G:the:influenza:pandemic
10264-410X:2010:Van Der Weijden C:the:duty:to
10264-410X:2010:Schwarzinger M:positive:attitudes:of
10264-410X:2010:Lee B:a:computer:simulation
10264-410X:2009:Shoji Y:immunogenicity:of:hemagglutinin
10264-410X:2009:Patel A:evaluation:of:conserved
10264-410X:2009:Pareek M:willingness:of:healthcare
10264-410X:2009:Lau Y:a:tlr:ligand
10264-410X:2009:Ikeno D:a:prime:boost
10264-410X:2009:De Vries J:incorporation:of:lpxl
10264-410X:2008:Williams T:quantification:of:influenza
10264-410X:2008:Toro H:protection:of:chickens
10264-410X:2008:Nolan T:safety:and:immunogenicity
10264-410X:2008:Mylius S:optimal:allocation:of
10264-410X:2008:Hu A:microcarrier:based:mdck
10264-410X:2007:Laddy D:immunogenicity:of:novel
10264-410X:2007:Hughes K:yield:increases:in
10264-410X:2006:Oxford J:scientific:lessons:from
10264-410X:2006:Kieny M:a:global:pandemic
10264-410X:2006:Hak E:modelling:the:health
10264-410X:2006:Flahault A:strategies:for:containing
10264-410X:2006:Desheva J:characterization:of:an
10264-410X:2006:Chowell G:estimation:of:the
10264-410X:2005:Pushko P:influenza:virus:like
10264-410X:2005:Oxford J:a:new:european
10264-410X:2005:Oxford J:a:hypothesis:the
10264-410X:2003:Wood J:the:influenza:vaccine
10264-410X:2003:Cox N:influenza:pandemic:planning
10264-410X:2002:Hilleman M:realities:and:enigmas
10245-7466:2009:Raude J:les:francais:a
10196-6553:2013:Beckman S:evaluation:of:respiratory
10196-6553:2009:Hashikura M:stockpile:of:personal
10196-6553:2007:Goldrick B:pandemic:influenza:what
10196-0644:2010:Kellermann A:web:based:self
10195-6701:2011:Zhou Y:seroprevalence:of:antibody
10195-6701:2009:Phin N:personal:protective:equipment
10195-6701:2006:Tang J:factors:involved:in
10193-936X:1996:Glezen W:emerging:infections:pandemic
10166-3542:2013:Chen H:inhibitory:and:combinatorial
10166-3542:2012:Lee S:targeting:the:host
10166-3542:2010:Sakabe S:a:cross:reactive
10166-0934:2010:Ducatez M:genotyping:assay:for
10166-0934:2010:Cheung T:evaluation:of:novel
10146-6615:2013:Sam I:seroprevalence:of:seasonal
10146-6615:2013:Pilorge L:rhinoviruses:as:an
10146-6615:2012:Thiberville S:the:viral:etiology
10146-6615:2012:Poeppl W:pre:and:post
10146-6615:2012:Boonarkart C:case:report:increased
10146-6615:2011:Samuel D:monoclonal:antibodies:to
10146-6615:2010:Zaraket H:antiviral:drug:susceptibilities
10146-6615:2010:Mak G:sero:immunity:and
10146-6615:2010:Liu S:pandemic:characteristics:and
10146-6615:2010:Lam W:development:and:comparison
10146-6615:2008:Lin J:genetic:and:antigenic
10146-6615:2007:Reece P:neuraminidase:inhibitor:resistance
10146-6615:2007:Ichinohe T:prophylactic:effects:of
10146-6615:2004:Yap F:excess:hospital:admissions
10143-005X:2008:Li F:finding:the:real
10143-005X:2006:Doyle A:influenza:pandemic:preparedness
10141-9889:2013:Sherlaw W:why:the:french
10140-6736:2006:Coker R:pandemic:influenza:preparedness
10140-6736:2005:Tsang K:h:n:influenza
10140-6736:1996:Jack D:getting:ready:for
10140-6736:1971:Janerich D:relationship:between:the
10125-1562:2007:Nishiura H:household:and:community
10125-1562:2006:Bhatia R:preventing:avian:influenza
10105-2896:2011:Dormitzer P:influenza:vaccine:immunology
10105-2896:2008:Maines T:pathogenesis:of:emerging
10098-7921:2005:Smil V:the:next:years
10095-1137:2011:Veguilla V:sensitivity:and:specificity
10095-1137:2011:Raboni S:laboratory:diagnosis:epidemiology
10095-1137:2009:Leblanc J:switching:gears:for
10095-1137:2006:Lodes M:use:of:semiconductor
10095-1137:2000:Fouchier R:detection:of:influenza
10091-6765:2011:Singer A:assessing:the:ecotoxicologic
10090-3493:2010:Mitchell M:a:systematic:review
10090-0036:2014:Vellozzi C:cumulative:risk:of
10090-0036:2012:Gilchrist S:benefits:and:effectiveness
10090-0036:2009:Vaughan E:effective:health:risk
10090-0036:2009:Stevenson E:pandemic:influenza:planning
10090-0036:2009:Steege A:pandemic:influenza:and
10090-0036:2009:Rust G:role:of:the
10090-0036:2009:Maruschak L:pandemic:influenza:and
10090-0036:2009:Hutchins S:protection:of:racial
10090-0036:2009:Hobday R:the:open:air
10090-0036:2009:Heffelfinger J:pandemic:influenza:implications
10090-0036:2009:Groom A:pandemic:influenza:preparedness
10090-0036:2009:Farrell R:pandemic:influenza:and
10090-0036:2009:Campbell V:preparing:for:and
10090-0036:2009:Bouye K:pandemic:influenza:preparedness
10090-0036:2008:Doshi P:trends:in:recorded
10070-217X:2009:Yen H:pandemic:influenza:as
10070-217X:2009:O Neill E:generation:and:characterization
10070-217X:2009:Horimoto T:designing:vaccines:for
10070-217X:2009:Baylor N:considerations:for:licensure
10066-4812:2013:Everts J:announcing:swine:flu
10066-4812:2009:Wallace R:breeding:influenza:the
10048-9697:2008:Bartels P:the:environmental:fate
10043-3144:2010:Ramjeesingh D:an:intense:influenza
10042-9686:2012:Van Kerkhove M:epidemic:and:intervention
10042-9686:2012:Rajatonirina S:short:message:service
10042-6822:1984:Nakajima K:genetic:relatedness:between
10041-1132:2012:Kreil T:preparation:of:commercial
10041-1132:2010:Wong H:practical:limitations:of
10041-1132:2010:Tsubokura M:the:impact:of
10041-1132:2010:Kamp C:management:of:blood
10041-1132:2007:Zimrin A:planning:for:pandemic
10041-1132:2007:Kreil T:h:n:influenza
10040-6376:2010:Nguyen Van Tam J:risk:factors:for
10040-6376:2010:Fajardo Dolci G:clinical:characteristics:of
10037-9085:2011:Staikowsky F:caracteristiques:des:syndromes
10037-5675:2011:Siau C:influenza:a:h
10037-5675:2010:Voo T:influenza:pandemic:and
10036-8075:2009:Fraser C:pandemic:potential:of
10036-8075:2009:Ekiert D:antibody:recognition:of
10036-8075:1997:Taubenberger J:initial:genetic:characterization
10036-5548:2008:Kolte I:the:spanish:flu
10033-3549:2011:Lovegrove M:emergency:department:visits
10033-3549:2010:Tomes N:destroyer:and:teacher
10033-3549:2010:Stern A:better:off:in
10033-3549:2010:Keeling A:alert:to:the
10033-3549:2010:Byerly C:the:u:s
10033-3549:2010:Bristow N:it:s:as
10032-5473:2010:To K:concurrent:comparison:of
10032-5473:2007:Sellwood C:bird:flu:if
10028-4793:2010:Cowling B:comparative:epidemiology:of
10028-1042:1994:Ertel S:influenza:pandemics:and
10028-0836:2012:Morens D:engineering:h:n
10028-0836:2012:Everitt A:ifitm:restricts:the
10028-0836:2011:Vijaykrishna D:long:term:evolution
10028-0836:2009:Smith G:origins:and:evolutionary
10028-0836:2009:Neumann G:emergence:and:pandemic
10028-0836:2009:Ginsberg J:detecting:influenza:epidemics
10028-0836:2008:Cauchemez S:estimating:the:impact
10028-0836:2006:Kash J:genomic:analysis:of
10028-0836:2006:Ferguson N:strategies:for:mitigating
10028-0836:2005:Taubenberger J:characterization:of:the
10028-0836:2005:Ferguson N:strategies:for:containing
10028-0836:2004:Kobasa D:enhanced:virulence:of
10026-4695:2010:Van Rijswoud E:virology:experts:in
10025-729X:2010:Seale H:examining:the:knowledge
10025-729X:2010:Flint S:disproportionate:impact:of
10025-729X:2010:Beaman M:pandemic:influenza:testing
10025-729X:2009:Senanayake S:a:pandemic:that
10025-729X:2009:Seale H:the:community:s
10025-729X:2009:Mccaw J:understanding:australia:s
10025-729X:2008:Anikeeva O:how:will:australian
10025-729X:2006:Horvath J:the:australian:response
10025-729X:2006:Harrod M:antivirals:in:the
10025-729X:2006:Collignon P:infection:control:and
10025-729X:2006:Boyd M:pandemic:influenza:clinical
10025-7273:2005:Reid A:the:effects:of
10025-7273:2002:Langford C:the:age:pattern
10025-6196:2010:Tosh P:influenza:vaccines:from
10025-6196:2010:Sullivan S:h:n:influenza
10025-6196:2004:Trampuz A:avian:influenza:a
10024-7758:2009:Beigi R:acceptance:of:a
10022-538X:2012:Wong D:comparable:fitness:and
10022-538X:2011:Hillaire M:characterization:of:the
10022-538X:2011:Cline T:increased:pathogenicity:of
10022-538X:2011:Chan R:tissue:tropism:of
10022-538X:2010:Khatri M:swine:influenza:h
10022-538X:2010:Boon A:cross:reactive:neutralizing
10022-538X:2009:Perrone L:intranasal:vaccination:with
10022-538X:2009:Middleton D:evaluation:of:vaccines
10022-538X:2009:Kugel D:intranasal:administration:of
10022-538X:2009:Dunham E:different:evolutionary:trajectories
10022-538X:2008:Murakami S:growth:determinants:for
10022-538X:2008:Bouvier N:oseltamivir:resistant:influenza
10022-538X:2007:Yen H:neuraminidase:inhibitor:resistant
10022-538X:2007:Kochs G:multiple:anti:interferon
10022-538X:2005:Tumpey T:pathogenicity:of:influenza
10022-5045:2009:Eyler J:the:fog:of
10022-4391:2013:Miller J:use:of:nonpharmaceutical
10022-3549:2011:Andrianov A:pcpp:formulated:h
10022-3166:2009:Schwerbrock N:fish:oil:fed
10022-3069:2001:Reid A:experimenting:on:the
10022-3069:2001:Mccall S:influenza:rna:not
10022-1899:2012:Orelle A:epidemiological:and:virological
10022-1899:2012:Kouassi D:vulnerable:groups:within
10022-1899:2012:Jackson L:immunogenicity:and:safety
10022-1899:2012:Heraud J:spatiotemporal:circulation:of
10022-1899:2011:Launay O:safety:and:immunogenicity
10022-1899:2011:Bloom Feshbach K:natality:decline:and
10022-1899:2010:Van Den Brand J:severity:of:pneumonia
10022-1899:2010:Kobinger G:assessment:of:the
10022-1899:2010:Chowell G:mortality:patterns:associated
10022-1899:2010:Chien Y:efficacy:of:whole
10022-1899:2009:Ehrlich H:a:cell:culture
10022-1899:2008:Miller M:prioritization:of:influenza
10022-1899:2008:Hoelscher M:a:broadly:protective
10022-1899:2008:Fineberg H:preparing:for:avian
10022-1899:2008:Barry J:cross:protection:between
10022-1899:2008:Barrett R:stigma:in:the
10022-1899:2008:Andreasen V:epidemiologic:characterization:of
10022-1899:2007:Morens D:the:influenza:pandemic
10022-1899:2006:Whitley R:seasonal:and:pandemic
10022-1899:2006:Fauci A:seasonal:and:pandemic
10022-1899:2005:Viboud C:multinational:impact:of
10022-1899:1998:Stilianakis N:emergence:of:drug
10022-1899:1997:Webster R:predictions:for:future
10022-1899:1997:Patriarca P:influenza:pandemic:preparedness
10022-1899:1997:Monto A:prospects:for:pandemic
10022-1899:1977:Hilleman M:serologic:responses:to
10021-8537:1981:Ohadike D:the:influenza:pandemic
10021-2571:2003:Donatelli I:who:influenza:global
10020-1324:2010:Gilbert C:novel:h:n
10019-5456:2009:Sebastian M:swine:origin:influenza
10018-2648:2013:Fletcher A:reviews:and:short
10014-2972:2011:Lee M:m:specific:reverse
10012-835X:2005:Adungo F:influenza:the:next
10012-3692:2010:Hui D:clinical:management:of
10012-3692:2009:Hui D:exhaled:air:and
10012-3692:2008:Rubinson L:definitive:care:for
10012-3692:2006:Wong S:avian:influenza:virus
10009-9236:2007:Hoelscher M:new:pre:pandemic
10009-9236:2007:Gray G:the:importance:of
10009-9147:2010:Poon L:rapid:detection:of
10009-9147:2009:Poon L:molecular:detection:of
10008-4263:2005:Tam T:fortune:favours:the
10008-4263:2005:Kort R:ensuring:a:broad
10008-4263:2004:Doxtator L:responding:to:pandemic
10007-5140:2003:Afkhami A:compromised:constitutions:the
10007-5140:2002:Johnson N:updating:the:accounts
10007-1420:2005:Stephenson I:influenza:current:threat
10007-1048:2010:Launes C:pandemic:influenza:a
10006-4971:2010:Casper C:how:i:treat
10003-9888:2011:Smith H:are:the:uk
10003-9888:2009:Ercole A:modelling:the:impact
10003-9888:2008:Nicoll A:children:avian:influenza
10003-4878:2009:Viscusi D:evaluation:of:five
10003-4819:2014:Khazeni N:health:and:economic
10003-4819:2011:Tsatsaris V:maternal:immune:response
10003-4819:2009:Khazeni N:effectiveness:and:cost
10003-2409:2005:Menon D:modelling:the:impact
10002-9629:2010:Farley M:h:n:influenza
10002-9483:2009:Sawchuk L:brief:communication:rethinking
10002-9440:2010:Shieh W:pandemic:influenza:a
10002-9440:2010:Chan M:tropism:and:innate
10002-9378:2012:Rasmussen S:practices:of:obstetrician
10002-9378:2011:Mendez Figueroa H:neonatal:characteristics:and
10002-9262:2014:Pelat C:optimizing:the:precision
10002-9262:2011:Fraser C:influenza:transmission:in
10002-9262:2009:Wood J:optimal:dosing:and
10002-9262:2004:Reichert T:influenza:and:the
10002-8614:2014:Lum H:pandemic:influenza:plans
10002-8614:2011:Enserink R:absence:of:influenza
10002-8614:2007:Mody L:pandemic:influenza:planning
10001-706X:2002:Capua I:avian:influenza:and
10001-5172:2012:Brink M:respiratory:support:during
10001-5172:2010:Pahlman I:pandemic:influenza:human

Manipulations en shell (Unix/Dilib)

HfdCat /Users/jacquesducloy/Documents/WicriRoot/Wicri/Sante/explor/PandemieGrippale.storage/PandemieGrippaleV1/Data/Main/Curation/DoubleIdat.i.hfd| SxmlCut idx/l | grep ...  

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021